Cargando…
Validation of a Transcriptome-Based Assay for Classifying Cancers of Unknown Primary Origin
INTRODUCTION: Cancers assume a variety of distinct histologies, and may originate from a myriad of sites including solid organs, hematopoietic cells, and connective tissue. Clinical decision-making based on consensus guidelines such as the National Comprehensive Cancer Network (NCCN) is often predic...
Autores principales: | Michuda, Jackson, Breschi, Alessandra, Kapilivsky, Joshuah, Manghnani, Kabir, McCarter, Calvin, Hockenberry, Adam J., Mineo, Brittany, Igartua, Catherine, Dudley, Joel T., Stumpe, Martin C., Beaubier, Nike, Shirazi, Maryam, Jones, Ryan, Morency, Elizabeth, Blackwell, Kim, Guinney, Justin, Beauchamp, Kyle A., Taxter, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300170/ https://www.ncbi.nlm.nih.gov/pubmed/37099070 http://dx.doi.org/10.1007/s40291-023-00650-5 |
Ejemplares similares
-
Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort
por: Leibowitz, Benjamin D., et al.
Publicado: (2022) -
Assessing the utility of molecular diagnostic classification for cancers of unknown primary
por: Moore, Elle C., et al.
Publicado: (2023) -
Clinical validation of the tempus xT next-generation targeted oncology sequencing assay
por: Beaubier, Nike, et al.
Publicado: (2019) -
Multi-Field-of-View Deep Learning Model Predicts Nonsmall Cell Lung Cancer Programmed Death-Ligand 1 Status from Whole-Slide Hematoxylin and Eosin Images
por: Sha, Lingdao, et al.
Publicado: (2019) -
Computational and experimental methods for classifying variants of unknown clinical significance
por: Spielmann, Malte, et al.
Publicado: (2022)